Is Antivenom immunoglobulin registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 1 valid registration of Antivenom immunoglobulin, including POLYVALENT SCORPION ANTIVENOM-EQUINE (1 ml, Solution, SAR 1283.75).

Is Antivenom immunoglobulin on the WHO Model List of Essential Medicines?

Yes — 19.2. Immunologicals > Sera, immunoglobulins and monoclonal antibodies (core list): Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified.

Active substance

Antivenom immunoglobulin

SFDA 3
WHO EML 1

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
POLYVALENT SCORPION ANTIVENOM-EQUINE	1 ml	Solution · Intravenous use	10 Ampoule	SAR 1283.75	Biological · Prescription	NATIONAL ANTIVENOM AND VACCINE PRODUCTION CENTER	Valid
COBRA ANTIVENOM (EQUINE) AMP		Solution · Intravenous use	5 Ampoule	SAR 725.70	Biological · Prescription	NATIONAL ANTIVENOM AND VACCINE PRODUCTION CENTER	Invalid · Not Marketed
COBRA ANTIVENOM (EQUINE) AMP		Solution · Intravenous use	1 Ampoule	SAR 151.75	Biological · Prescription	NATIONAL ANTIVENOM AND VACCINE PRODUCTION CENTER	Invalid · Not Marketed

WHO WHO Model List of Essential Medicines (2025)

19.2. Immunologicals > Sera, immunoglobulins and monoclonal antibodies · core
Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified
Parenteral > General injections > IV:

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.